{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-016777","form_type":"8-K","ticker":"LPCN","cik":"0001535955","company_name":"Lipocine Inc.","filed_at":"2024-04-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.886887+00:00","generated_at":"2026-06-03T06:27:20.412561+00:00","sec_items":["1.01","1.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Lipocine enters new $10.6M ATM sales agreement with A.G.P., terminates prior Cantor facility","bullets":["Entered ATM agreement with A.G.P./Alliance Global Partners to sell up to $10,616,169 of common stock at market prices.","A.G.P. will receive 3.0% of aggregate gross proceeds from each sale under the agreement.","Terminated prior ATM agreement with Cantor Fitzgerald & Co., effective immediately, to enter new facility.","Either party may terminate the new agreement upon ten days' prior notice; no obligation to sell shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-016777","json":"https://secwatch.observer/filing/0001493152-24-016777.json","markdown":"https://secwatch.observer/filing/0001493152-24-016777.md","text":"https://secwatch.observer/filing/0001493152-24-016777.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1535955/000149315224016777/0001493152-24-016777-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1535955/000149315224016777/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T06:27:20.412561+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2ed5ea9b98fb4be39602e421bd3583fecd0c9aa2","claim":"Lipocine Inc. entered into ATM Agreement with A.G.P./Alliance Global Partners valued at up to $10,616,169 of Shares; 3.0% of aggregate gross proceeds per sale (effective 2024-04-26).","evidence_excerpt":"On April 26, 2024, Lipocine Inc. (the “Company”), entered into a sales agreement (the “ATM Agreement”) with A.G.P./Alliance Global Partners (“A.G.P.”), as sales agent, pursuant to which the Company may offer and sell shares of common stock, par value $0.0001 per share (the “Shares”), from time to time, in an at-the-market public offering.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315224016777/0001493152-24-016777-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"A.G.P./Alliance Global Partners"},{"label":"Value","value":"up to $10,616,169 of Shares; 3.0% of aggregate gross proceeds per sale"},{"label":"Effective","value":"2024-04-26"}],"fact_type":"material_agreement"},{"claim_id":"e0d1e950474ba07f93ae5c6658ddc8c1a32e3580","claim":"Lipocine Inc. terminated Controlled Equity Offering Sales Agreement with Cantor Fitzgerald & Co. valued at terminated effective immediately upon notice; waiver of notice period (effective 2024-04-24).","evidence_excerpt":"On April 24, 2024, the Company provided notice to Cantor Fitzgerald & Co. (“Cantor”) of its election to terminate the Controlled Equity Offering SM Sales Agreement between them dated March 6, 2017 (the “Sales Agreement”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315224016777/0001493152-24-016777-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"Cantor Fitzgerald & Co."},{"label":"Value","value":"terminated effective immediately upon notice; waiver of notice period"},{"label":"Effective","value":"2024-04-24"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}